AIMS/HYPOTHESIS: The AGE receptors 1, 2 and 3, which are encoded by DDOST, PRKCSH and LGALS3, respectively, may be involved in the pathogenesis of diabetic complications. We sought to find out whether these genes are associated with diabetic nephropathy, cardiovascular disease and type 1 diabetes or related quantitative traits. METHODS: Using the Tagger program, we selected 28 single nucleotide polymorphisms (SNPs) based on the HapMap Centre d'Etude du Polymorphisme (Utah residents with northern and western European ancestry) data. The SNPs were genotyped in 2,719 Finnish patients with type 1 diabetes and tested for association with diabetic nephropathy (821 cases, 1,060 controls), cardiovascular disease and related quantitative traits. For association analysis with type 1 diabetes, 703 non-diabetic control participants were genotyped. RESULTS: We found evidence of genotype association between diabetic nephropathy and the SNPs rs2170336 in DDOST (p = 0.03), rs311788 in PRKCSH (p = 0.04) and rs311778 in PRKCSH (p = 0.02). However, these associations did not reach the significance limit of 0.0008 adjusted for multiple testing. None of the DDOST, PRKCSH or LGALS3 SNPs were associated with quantitative traits related to diabetic nephropathy, including AER and estimated GFR. No associations were found between the SNPs and cardiovascular disease, blood pressure, serum lipid levels or type 1 diabetes. CONCLUSIONS/ INTERPRETATION: The common SNPs tested in DDOST, PRKCSH and LGALS3 do not seem to be associated with diabetic micro- or macrovascular complications or with type 1 diabetes in Finnish patients.
AIMS/HYPOTHESIS: The AGE receptors 1, 2 and 3, which are encoded by DDOST, PRKCSH and LGALS3, respectively, may be involved in the pathogenesis of diabetic complications. We sought to find out whether these genes are associated with diabetic nephropathy, cardiovascular disease and type 1 diabetes or related quantitative traits. METHODS: Using the Tagger program, we selected 28 single nucleotide polymorphisms (SNPs) based on the HapMap Centre d'Etude du Polymorphisme (Utah residents with northern and western European ancestry) data. The SNPs were genotyped in 2,719 Finnish patients with type 1 diabetes and tested for association with diabetic nephropathy (821 cases, 1,060 controls), cardiovascular disease and related quantitative traits. For association analysis with type 1 diabetes, 703 non-diabetic control participants were genotyped. RESULTS: We found evidence of genotype association between diabetic nephropathy and the SNPs rs2170336 in DDOST (p = 0.03), rs311788 in PRKCSH (p = 0.04) and rs311778 in PRKCSH (p = 0.02). However, these associations did not reach the significance limit of 0.0008 adjusted for multiple testing. None of the DDOST, PRKCSH or LGALS3 SNPs were associated with quantitative traits related to diabetic nephropathy, including AER and estimated GFR. No associations were found between the SNPs and cardiovascular disease, blood pressure, serum lipid levels or type 1 diabetes. CONCLUSIONS/ INTERPRETATION: The common SNPs tested in DDOST, PRKCSH and LGALS3 do not seem to be associated with diabetic micro- or macrovascular complications or with type 1 diabetes in Finnish patients.
Authors: Changyong Lu; John Cijiang He; Weijing Cai; Huixian Liu; Li Zhu; Helen Vlassara Journal: Proc Natl Acad Sci U S A Date: 2004-08-02 Impact factor: 11.205
Authors: Per E Lundmark; Ulrika Liljedahl; Dorret I Boomsma; Heikki Mannila; Nicholas G Martin; Aarno Palotie; Leena Peltonen; Markus Perola; Tim D Spector; Ann-Christine Syvänen Journal: Eur J Hum Genet Date: 2008-04-09 Impact factor: 4.246
Authors: G Prevost; I Fajardy; C Besmond; B Balkau; J Tichet; P Fontaine; P M Danze; M Marre Journal: Diabetes Metab Date: 2005-02 Impact factor: 6.041
Authors: Kim Pettersson-Fernholm; Carol Forsblom; Barry I Hudson; Markus Perola; Peter J Grant; Per-Henrik Groop Journal: Diabetes Date: 2003-03 Impact factor: 9.461
Authors: Markku Saraheimo; Carol Forsblom; Lena Thorn; Johan Wadén; Milla Rosengård-Bärlund; Outi Heikkilä; Kustaa Hietala; Daniel Gordin; Jan Frystyk; Allan Flyvbjerg; Per-Henrik Groop Journal: Diabetes Care Date: 2008-03-17 Impact factor: 19.112
Authors: Aowen Zhuang; Felicia Y T Yap; Domenica McCarthy; Chris Leung; Karly C Sourris; Sally A Penfold; Vicki Thallas-Bonke; Melinda T Coughlan; Benjamin L Schulz; Josephine M Forbes Journal: Sci Rep Date: 2019-09-20 Impact factor: 4.379